Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting
Background : The factors associated with non-adherence to obesity treatment using liraglutide 3.0 mg in a real-world setting remain elusive. Methods : We performed a secondary data analysis of 769 participants treated with liraglutide 3.0 mg from December 2017 to June 2020 at nine Korean hospitals....
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for the Study of Obesity
2022-09-01
|
Series: | Journal of Obesity & Metabolic Syndrome |
Subjects: | |
Online Access: | http://journaleditor.inforang.com/journal/view.html?doi=10.7570/jomes22029 |